STOK logo
Stoke Therapeutics, Inc.(STOK)
Last print unknown agoAbout this dataData status
$24.82▲0.65 (2.69%)Stale · unknown oldEarnings · Nov 3

STOK Operating Cash Flow (Statement)

-$177.99MTTM · USD

Period ending:

STOK FY Cash from OperationsUSD
STOK FY Cash from Operations2017-12-31: -$5.38M2018-12-31: -$10.96M2019-12-31: -$31.06M2020-12-31: -$42.22M2021-12-31: -$66.91M2022-12-31: -$31.87M2023-12-31: -$81.07M2024-12-31: -$86.85M2025-12-31: $45.59M$45.59M-$86.85M
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

STOK operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Stoke Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
45,585,000
-86,851,000
-81,067,000
-31,866,000
-66,907,000
-42,221,000
-31,055,000
-10,964,000
-5,384,000

Compare operating cash flow (statement)

All STOK financial metrics · STOK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.